检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

High SLC20A1 Expression Is Associated With Poor Prognosis for Radiotherapy of Estrogen Receptor-positive Breast Cancer.

Chotaro Onaga,Shoma Tamori,Izumi Matsuoka,Ayaka Ozaki,Hitomi Motomura,Yuka Nagashima,Tsugumichi Sato,Keiko Sato,Kouji Tahata,Yuyun Xiong,Yoshio Nakano,Yasunari Mano,Satoru Miyazaki,Kazunori Sasaki,Shigeo Ohno,Kazunori Akimoto

Cancer diagnosis & prognosis（2022）

引用 1|浏览7
暂无评分
摘要
SLC20A1 can be used as a prognostic marker for the prediction of the efficacy of radiotherapy for luminal A and luminal B breast cancers.
更多
查看译文
关键词
Breast cancer,ER+ breast cancer,SLC20A1,radiation resistance,radiotherapy
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要